In the “Bacterial Genome Architect Project (BGD)”, a synthetic genome of E. coli will be prepared by conventional method with desired characteristics for industrial applications. Project leader is Associate Professor Yasunori AIZAWA, industrial partner is Logomix Inc., a synthetic biology startup company founded in Tokyo in 2019, based on the IP of Dr. Yasunori Aizawa.
Nikkei Biotech news release, September 10, 2020
Tokyo Institute of Technology launches program on artificial E. coli genome